Skip to main content
. 2023 Nov 16;13:20135. doi: 10.1038/s41598-023-47472-3

Figure 3.

Figure 3

Validation of the disulfidptosis-associated lncRNA model. (A) PCA of model-related lncRNAs. (B) tSNE analysis of model-related lncRNAs. (C) Progression-free survival analysis. (DF) The overall survival of the TCGA set, the testing set and the training set. (GI) The risk index of the high- and low-risk groups in the three sets. (JL) The model lncRNA expression of the high- and low-risk groups in the three sets. (M) Overall survival analysis of GIHCG in external datasets.